









Markets
/
Stocks
/
nasdaq-acrv
/

Acrivon Therapeutics Inc

ACRV

2.160USD

-0.100-4.42%

Close 12/19, 16:00（ET）Quotes delayed by 15 min

68.15MMarket Cap

LossP/E TTM



Acrivon Therapeutics Inc

2.160

-0.100-4.42%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Acrivon Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

29.09%-12.28M

-19.47%-16.61M

-14.35%-19.54M

-40.38%-17.36M

-76.66%-17.32M

-52.58%-13.90M

-50.42%-17.08M

-32.20%-12.37M

-50.38%-9.81M

---9.11M

---11.36M

---9.35M

---6.52M

Net income from continuing operations

18.75%-18.23M

-11.75%-21.01M

-19.37%-19.68M

-18.59%-22.83M

-55.13%-22.44M

-35.10%-18.80M

-29.24%-16.49M

-115.61%-19.25M

-57.27%-14.47M

---13.91M

---12.76M

---8.93M

---9.20M

Operating gains losses

39.04%349.00K

46.93%335.00K

38.84%311.00K

103.36%303.00K

88.72%251.00K

76.74%228.00K

79.20%224.00K

19.20%149.00K

14.66%133.00K

--129.00K

--125.00K

--116.00K

Other non-cash items

123.24%225.00K

109.43%82.00K

68.27%-112.00K

-34.57%-654.00K

-77.94%-968.00K

-51.83%-870.00K

62.53%-353.00K

-48.17%-486.00K

-27300.00%-544.00K

---573.00K

---942.00K

---328.00K

--2.00K

Change in working capital

-32.26%1.47M

-97.36%52.00K

-0.87%-3.84M

-49.22%2.12M

17.42%2.16M

-23.01%1.97M

-786.51%-3.81M

323.09%4.17M

-19.59%1.84M

--2.56M

---430.00K

---1.87M

--2.29M

-Change in prepaid expenses

-176.90%-223.00K

157.51%703.00K

232.86%466.00K

-377.38%-466.00K

491.89%290.00K

-80.82%273.00K

-76.39%140.00K

106.73%168.00K

-105.10%-74.00K

--1.42M

--593.00K

---2.50M

--1.45M

-Change in other current assets

----

--0.00

---1.18M

----

Cash from non-recurring investing activities

Cash from operating activities

29.09%-12.28M

-19.47%-16.61M

-14.35%-19.54M

-40.38%-17.36M

-76.66%-17.32M

-52.58%-13.90M

-50.42%-17.08M

-32.20%-12.37M

-50.38%-9.81M

---9.11M

---11.36M

---9.35M

---6.52M

Investing cash flow

Net cash from continuing investing activities

-9.10%899.00K

259.85%493.00K

-92.88%58.00K

-28.15%827.00K

--989.00K

22.32%137.00K

3160.00%815.00K

358.57%1.15M

-100.00%0.00

--112.00K

--25.00K

--251.00K

--426.00K

Capital expenditures

-9.10%899.00K

259.85%493.00K

-92.88%58.00K

-28.15%827.00K

--989.00K

22.32%137.00K

3160.00%815.00K

358.57%1.15M

-100.00%0.00

--112.00K

--25.00K

--251.00K

--426.00K

Net cash flow from disposal of fixed assets

-9.10%899.00K

259.85%493.00K

-92.88%58.00K

-28.15%827.00K

--989.00K

22.32%137.00K

3160.00%815.00K

358.57%1.15M

-100.00%0.00

--112.00K

--25.00K

--251.00K

--426.00K

Net cash flow from investment products

-59.94%6.81M

122.69%19.94M

189.15%19.27M

-29.73%15.24M

1021.37%17.00M

-551.96%-87.91M

-28.73%6.67M

122.87%21.69M

103.39%1.52M

--19.45M

--9.35M

---94.82M

---44.69M

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

-63.08%5.91M

122.09%19.45M

228.44%19.21M

-29.82%14.41M

956.13%16.01M

-555.29%-88.04M

-37.28%5.85M

121.60%20.54M

103.36%1.52M

--19.34M

--9.33M

---95.07M

---45.12M

Financing cash flow

Cash flow from continuous financing activities

92.22%-117.00K

-100.08%-97.00K

-99.42%-343.00K

67.83%-647.00K

-2028.21%-1.50M

32446.17%123.35M

---172.00K

-101.97%-2.01M

155.71%78.00K

--379.00K

--0.00

--101.86M

---140.00K

Net cash flow from common stock issuance/repurchase

----

100.00%0.00

---307.00K

--63.85M

---85.00K

-154.98%-1.03M

----

--1.88M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

----

Proceeds from stock option exercised by employees

--0.00

-100.00%0.00

-98.73%1.00K

-100.00%0.00

--11.00K

--79.00K

--318.00K

225.00%78.00K

----

--0.00

--24.00K

Proceeds from issuance of warrants

----

--0.00

--60.00M

----

Net cash flow from other financing activities

90.23%-117.00K

80.98%-97.00K

-107.23%-344.00K

50.12%-647.00K

---1.20M

---510.00K

---166.00K

-101.30%-1.30M

100.00%0.00

----

--99.98M

---164.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

92.22%-117.00K

-100.08%-97.00K

-99.42%-343.00K

67.83%-647.00K

-2028.21%-1.50M

32446.17%123.35M

---172.00K

-101.97%-2.01M

155.71%78.00K

--379.00K

--0.00

--101.86M

---140.00K

Net cash flow

Beginning cash balance

-9.33%42.10M

57.26%39.35M

9.85%40.02M

44.07%43.61M

20.65%46.43M

-10.23%25.02M

21.81%36.43M

-6.77%30.27M

-54.32%38.48M

--27.88M

--29.91M

--32.47M

--84.25M

Current period cash flow changes

-130.43%-6.49M

-87.18%2.74M

94.18%-664.00K

-158.37%-3.59M

65.71%-2.82M

101.82%21.40M

-461.82%-11.40M

340.49%6.16M

84.14%-8.21M

--10.61M

---2.03M

---2.56M

---51.78M

Ending cash balance

-18.35%35.61M

-9.33%42.10M

57.26%39.35M

9.85%40.02M

44.07%43.61M

20.65%46.43M

-10.23%25.02M

21.81%36.43M

-6.77%30.27M

--38.48M

--27.88M

--29.91M

--32.47M

Free cash flow

28.01%-13.18M

-21.82%-17.10M

-9.47%-19.59M

-34.55%-18.19M

-86.74%-18.31M

-52.21%-14.04M

-57.25%-17.90M

-40.73%-13.52M

-41.15%-9.81M

---9.22M

---11.38M

---9.61M

---6.95M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

